There are many treatment options for liver cancer, including surgery, radiotherapy, immunotherapy, adjuvant therapy, etc. Different treatment options determine the intensity of the tumor being controlled, and the prognosis and survival rate of patients are also different. Currently, liver cancer treatment is mainly surgical treatment, and 2/3 of patients will have recurrence after surgery, reducing the ultra-long survival of liver cancer patients, and radiotherapy can be performed after liver cancer surgery to eliminate the unresected residual lymph nodes, which can prevent recurrence and achieve the goal of improving patient survival.
Ultra-long-term survival of liver cancer is also very closely related to factors such as lymph node metastasis, family history, high cell differentiation, and age. The higher the degree of cell differentiation, the better the prognosis of the patient, and the lower the degree of differentiation, the poorer the prognosis and the relatively shorter the survival period. Lymph node metastasis is an independent factor in the prognosis of patients with liver cancer. Patients with metastasis have a worse prognosis than those without metastasis, and those with a positive family history of liver cancer are at high risk of developing the disease and have a poor prognosis.
In addition to the poor prognosis of liver cancer in patients who smoke and drink alcohol, factors that affect survival of liver cancer are influenced and interfered with by emotional, psychological, and social factors, which not only increase the incidence of liver cancer, but also are common factors that affect prognosis.